Literature DB >> 12352108

Enchondroma: a benign osseous lesion with high F-18 FDG uptake.

Natascha Döbert1, Christian Menzel, Ralf Ludwig, Uwe Berner, Michaela Diehl, Nadja Hamscho, Frank Grünwald.   

Abstract

A woman was referred for fluorodeoxyglucose positron emission tomography for the staging of a malignant melanoma. Although no signs of metastatic melanoma were evident on the whole-body scan, focally increased uptake within the femoral metaphysis was noted. Radiographic and magnetic resonance examinations revealed an enchondroma as the cause of the increased uptake. Histopathologic verification was obtained. The final diagnosis was actively proliferating enchondroma. A grade I chondrosarcoma could be ruled out. Enchondromas may be responsible for focally increased FDG uptake in bone lesions and must be considered when positron emission tomographic scans obtained with FDG are evaluated in cancer staging.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12352108     DOI: 10.1097/01.RLU.0000027743.04696.0D

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  5 in total

1.  [Comment on the work "Therapy of enchondroma in long bones" (H. Steckel, M. Oldenburg, R.T. Müller)].

Authors:  W Mutschler; W Sienel
Journal:  Unfallchirurg       Date:  2005-06       Impact factor: 1.000

Review 2.  The imaging of cartilaginous bone tumours. I. Benign lesions.

Authors:  H Douis; A Saifuddin
Journal:  Skeletal Radiol       Date:  2012-06-17       Impact factor: 2.199

Review 3.  Multiple metastasis-like bone lesions in scintigraphic imaging.

Authors:  Ying Zhang; Chunlei Zhao; Hongbiao Liu; Haifeng Hou; Hong Zhang
Journal:  J Biomed Biotechnol       Date:  2012-03-15

4.  Positron emission tomography/computed tomography imaging appearance of benign and classic "do not touch" osseous lesions.

Authors:  Stacey M Elangovan; Ronnie Sebro
Journal:  World J Radiol       Date:  2019-06-28

5.  Early Radiation-Induced Sarcoma in an Adolescent Treated for Relapsed Hodgkin Lymphoma with Nivolumab.

Authors:  Lukas Šalaševičius; Goda Elizabeta Vaitkevičienė; Ramunė Pasaulienė; Rosita Kiudelienė; Ernesta Ivanauskaitė-Didžiokienė; Donatas Vajauskas; Nemira Jurkienė; Jelena Rascon
Journal:  Medicina (Kaunas)       Date:  2020-03-31       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.